SPOTLIGHT -
EP. 1: Dysregulated Angiogenesis in Cancer
EP. 2: Therapeutic Targeting Against Abnormal Tumor Vasculature
EP. 3: Use of Bevacizumab for Lung Cancer
EP. 4: Ramucirumab for Squamous or Nonsquamous Lung Cancer
EP. 5: Combining Therapies with Antiangiogenic Antibodies
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making